Spray for Success
Vaccines are essential for public health and yet challenging to develop. We need more manufacturing techniques at our disposal.
Devon DuBose |
Vaccines have a huge impact on global health. According to the World Health Organization, measles vaccinations alone have saved over 17 million lives since 2000 (1), and some diseases, such as polio and small pox, have almost been eradicated from many countries because of vaccination. Today, companies are developing vaccines for emerging healthcare threats, including Zika and Ebola, as well as bioterrorism threats, such as anthrax.
Vaccine development, however, is a time- and cost-intensive process. Determining new, viable viral targets involves consideration of a range of factors, including the frequency of disease, virulence, mortality, access to healthcare administrators, location, and socioeconomic impacts. And many vaccines have to be stockpiled (particularly with bioterrorism), which creates additional challenges.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine